Alivexis

About:

Alivexis is a biotechnology company that engages in the research and development of custom medicine for the pharmaceutical industry.

Website: https://alivexis.com/

Top Investors: SBI Investment, SMBC Venture Capital, Mizuho Capital, SBI Group, JAFCO

Description:

Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.

Total Funding Amount:

$53.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2016-08-01

Founders:

Kazuki Ohno, Kimura Shun, Suguru Roy Kimura

Number of Employees:

11-50

Last Funding Date:

2022-03-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai